To include your compound in the COVID-19 Resource Center, submit it here.

Genocea, Auspex, NephroGenex file for IPO

Infectious disease company Genocea Biosciences Inc. (Cambridge, Mass.), rare neurology disease play Auspex Pharmaceuticals Inc. (La Jolla, Calif.) and kidney disease company NephroGenex Inc. (Research Triangle Park, N.C.) all filed

Read the full 307 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE